A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Juniper Research Reports: New Study Found the Number of People Using Digitial Therapeutics and Wellness Apps Will Grow from 627 Mil in 2020 to More Than 1.4 Bil in 2025

What To Know

  • By opening up digital therapeutics to Medicare, public health providers will become one of the biggest contributors to digital therapeutics revenue in 2025, to the tune of $19 billion globally.
  • Market Size 2020-2025, notes that following the advent of the pandemic, the Centers for Medicare and Medicaid Services (CMS) expanded the range of telehealth services available to the 40+ million beneficiaries of Medicare in the US.

October 27, 2020

Juniper Research reports a new study has found that the number of people using digital therapeutics and wellness apps will grow from 627 million in 2020 to more than 1.4 billion in 2025, after regulators responded to COVID-19 by loosening rules that had previously hindered the work of digital therapeutics developers.

Juniper Research notes the study also revealed that by 2021, over 44 million people will be using digital therapeutics to manage their healthcare. This is an increase of 288% over pre-pandemic usage levels in 2019; suggesting that digital therapeutics and wellness apps have become a lifeline for many people during the pandemic, as they were unable to leave their homes to receive help maintaining their physical and mental health.

For more insights, download their complimentary whitepaper: Has COVID-19 Made the Digital Therapeutics Market Healthier?

Expansion of Reimbursement Structures Driving Adoption in the US

The new report, Digital Therapeutics & Wellness: Disruption, Innovation Opportunities & Market Size 2020-2025, notes that following the advent of the pandemic, the Centers for Medicare and Medicaid Services (CMS) expanded the range of telehealth services available to the 40+ million beneficiaries of Medicare in the US. Between this and the aforementioned uptake in adoption by consumers, we anticipate that by 2025, an expected 652 million people globally will manage their healthcare through digital therapeutics; making them a key element of future health service delivery.

By opening up digital therapeutics to Medicare, public health providers will become one of the biggest contributors to digital therapeutics revenue in 2025, to the tune of $19 billion globally.

Health Insurers and Employers Contributing Majority of Future Revenue

With this broadening awareness, Juniper Research expects the value of the digital therapeutics and wellness market to grow from an expected $5.8 billion in 2020 to over $56 billion in 2025. This growth will be largely fed by acceptance of digital therapeutics technologies by institutions like health insurers and employer payers, who are expected to contribute over half of the digital therapeutics revenue.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.
SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.

By using this website you agree to accept Medical Device News Magazine Privacy Policy